Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trialDongsheng Wang, Xiaoling Xu, Liangye Sun et al.|Frontiers of Medicine|2021Cited by 80
Tocilizumab Ameliorates the Hypoxia in COVID-19 Moderate Patients with Bilateral Pulmonary Lesions: A Randomized, Controlled, Open-Label, Multicenter TrialDongsheng Wang, Xiaoling Xu, Binqing Fu et al.|SSRN Electronic Journal|2020Cited by 18
Acute Respiratory Distress Syndrome Caused by Occupational Exposure to Waterproofing Spray: A Case Report and Literature ReviewMeng Fu, Junqiang Zhang, Chun-Mei Feng et al.|Frontiers in Public Health|2022Cited by 5
Case report: Indolent drug-related pneumonitis with alectinib therapy in the treatment of non-small cell lung cancerXianmeng Chen, Xiaowen Hu, Daqing Xia et al.|Frontiers in Pharmacology|2022Cited by 3